Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

Español • Italiano • Sardu • English | PDF+


  Tuberculosis

  Free Subscription


15.07.2019

1 Antimicrob Agents Chemother
1 Clin Infect Dis
1 J Bacteriol
2 J Infect Dis
2 Lancet Infect Dis
1 Lancet Respir Med
2 PLoS Med
6 PLoS One
1 Trop Med Int Health


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. KIDWAI S, Bouzeyen R, Chakraborti S, Khare N, et al
    NU-6027 inhibits growth of Mycobacterium tuberculosis by targeting Protein Kinase D and Protein Kinase G.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00996.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  2. ARONSON JR, Rezvani AR, Subramanian A
    Incidence of Active Tuberculosis Following Hematopoietic Cell Transplantation: A Small but Real Threat.
    Clin Infect Dis. 2019 Jul 11. pii: 5531496. doi: 10.1093.
    PubMed     Text format    


    J Bacteriol

  3. BALLISTER ER, Samanovic MI, Darwin KH
    Mycobacterium tuberculosis Rv2700 Contributes to Cell Envelope Integrity and Virulence.
    J Bacteriol. 2019 Jul 8. pii: JB.00228-19. doi: 10.1128/JB.00228.
    PubMed     Text format     Abstract available


    J Infect Dis

  4. VERRALL AJ, Alisjahbana B, Apriani L, Novianty N, et al
    Early Clearance of Mycobacterium tuberculosis: The INFECT Case Contact Cohort Study in Indonesia.
    J Infect Dis. 2019 Jul 12. pii: 5531576. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. LALVANI A, Seshadri C
    Understanding How BCG Vaccine Protects Against Mycobacterium tuberculosis Infection: Lessons From Household Contact Studies.
    J Infect Dis. 2019 Jul 12. pii: 5531579. doi: 10.1093.
    PubMed     Text format    


    Lancet Infect Dis

  6. GARCIA-BASTEIRO AL, Jenkins HE, Rangaka M
    The burden of latent multidrug-resistant tuberculosis.
    Lancet Infect Dis. 2019 Jul 4. pii: S1473-3099(19)30271.
    PubMed     Text format    

  7. KNIGHT GM, McQuaid CF, Dodd PJ, Houben RMGJ, et al
    Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling.
    Lancet Infect Dis. 2019 Jul 4. pii: S1473-3099(19)30307.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  8. ATKINS KE, Lipsitch M
    Can antibiotic resistance be reduced by vaccinating against respiratory disease?
    Lancet Respir Med. 2018 Jul 31. pii: S2213-2600(18)30328.
    PubMed     Text format    


    PLoS Med

  9. OLLIARO PL, Vaillant M
    Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness.
    PLoS Med. 2019;16:e1002850.
    PubMed     Text format     Abstract available

  10. DAVIES G, Boeree M, Hermann D, Hoelscher M, et al
    Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs.
    PLoS Med. 2019;16:e1002851.
    PubMed     Text format     Abstract available


    PLoS One

  11. DE SCHACHT C, Mutaquiha C, Faria F, Castro G, et al
    Barriers to access and adherence to tuberculosis services, as perceived by patients: A qualitative study in Mozambique.
    PLoS One. 2019;14:e0219470.
    PubMed     Text format     Abstract available

  12. SARKAR S, Rivas-Santiago CE, Ibironke OA, Carranza C, et al
    Season and size of urban particulate matter differentially affect cytotoxicity and human immune responses to Mycobacterium tuberculosis.
    PLoS One. 2019;14:e0219122.
    PubMed     Text format     Abstract available

  13. ABDULLAHI OA, Ngari MM, Sanga D, Katana G, et al
    Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya.
    PLoS One. 2019;14:e0219191.
    PubMed     Text format     Abstract available

  14. BAIK Y, Fane O, Wang Q, Modongo C, et al
    Undetected tuberculosis at enrollment and after hospitalization in medical and oncology wards in Botswana.
    PLoS One. 2019;14:e0219678.
    PubMed     Text format     Abstract available

  15. COUVIN D, Reynaud Y, Rastogi N
    Two tales: Worldwide distribution of Central Asian (CAS) versus ancestral East-African Indian (EAI) lineages of Mycobacterium tuberculosis underlines a remarkable cleavage for phylogeographical, epidemiological and demographical characteristics.
    PLoS One. 2019;14:e0219706.
    PubMed     Text format     Abstract available

  16. KINIKAR A, Chandanwale A, Kadam D, Joshi S, et al
    High risk for latent tuberculosis infection among medical residents and nursing students in India.
    PLoS One. 2019;14:e0219131.
    PubMed     Text format     Abstract available


    Trop Med Int Health

  17. LIN M, Zhong Y, Chen Z, Lin C, et al
    High incidence of drug-resistant Mycobacterium tuberculosis in Hainan island, China.
    Trop Med Int Health. 2019 Jul 6. doi: 10.1111/tmi.13285.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: